David A. Siegel Immunome Inc. Transaction History
Two Sigma Advisers, LP
- $42.8 Billion
- Q1 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Immunome Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 11,400 shares of IMNM stock, worth $93,024. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,400
Previous 48,200
76.35%
Holding current value
$93,024
Previous $494,000
84.62%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IMNM
# of Institutions
149Shares Held
66.3MCall Options Held
47.3KPut Options Held
4.31M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.55MShares$61.6 Million0.03% of portfolio
-
Redmile Group, LLC San Francisco, CA5.36MShares$43.7 Million3.79% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.36MShares$35.6 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.31MShares$35.1 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$33.3 Million2.16% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $99M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...